Veterans

HR 586, the Vietnam Veterans Liver Fluke Cancer Study Act, directs the Department of Veterans Affairs (VA) to study cholangiocarcinoma (bile duct cancer) rates among veterans who served in the Vietnam theater during the Vietnam era. Using data from the VA Central Cancer Registry and CDC cancer registries, the study will compare cancer incidence rates between these veterans and the general U.S. population, broken down by age, gender, race, ethnicity, and location. The VA must submit an initial report to Congress within one year of the study’s completion, including findings and recommendations for addressing any identified health issues, with ongoing follow-up reports to track trends. This bill specifically affects Vietnam-era veterans who served in Vietnam, focusing on data collection and analysis rather than immediate policy changes.